Amputation; Traumatic, Arm, UpperNCT04803253
Study of the Social and Professional Reintegration Improvements Using a Set of Solutions for Upper Limb Amputation
A study testing ORTHOPUS prosthetic accessory: 0109 - Universal Wrist, ORTHOPUS prosthetic terminal device: 0112 - Hook and ORTHOPUS prosthetic terminal device: 0105 - Cosmetic Articulated Hand in people with Amputation; Traumatic, Arm, Upper and Amputation; Traumatic, Arm: Forearm, run by Orthopus at 3 sites in Nepal.
Trial summary
ORTHOPUS develops assistive technologies to address the lack of availability of medical devices in low and middle income countries. With the help of HI (Handicap International) Nepal, the need for upper limb prostheses was identified. Read more about this study
- Who is it for?
- Ages 20 to 50 years
- Conditions the study is for
- Amputation; Traumatic, Arm, Upper, Amputation; Traumatic, Arm: Forearm, Amputation; Traumatic, Hand, at Wrist Level
- What is being tested?
- ORTHOPUS prosthetic accessory: 0109 - Universal Wrist, ORTHOPUS prosthetic terminal device: 0112 - Hook and ORTHOPUS prosthetic terminal device: 0105 - Cosmetic Articulated Hand
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 14 participants
- Where
- 3 sitesNepal
- Study dates
- 6 Sep 2021to Feb 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 50 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Unilateral transradial or wrist-disarticulation amputee
- 20 to 50 years of age
- At least 1 year from date of amputation
- Have been using upper limb prosthesis previously
- Be able to independently provide informed and independant consent
- Be willing to comply with study procedures
- Independent function by self-report
- Free of any health ailment that would impair physical function
Who cannot join
- Congenital anomaly of upper limb
- Bilateral wrist disarticulation or transradial amputation
- Any condition that would prevent participation and pose increased risk (e.g. shoulder impingement, sub-acromial bursitis, severe arthritis of the shoulder, elbow, wrist, or fingers)
- Injuries of the upper limb within the past 90 days (surgeries, sprains, strains, or fractures).
- Younger than 20 or older than 50 years of age
- Unwillingness/inability to follow instructions
- History of acute or chronic skin breakdown on the residual limb
- Any health ailment that would impair physical function
Trial locations and contacts
3 sites in 1 country.
Nepal3 sites, 3 recruiting
- Recruiting
Community Based Rehabilitation
Biratnagar, 56613
Kanulal Chaudhary, 21531594 ext. +977, cbrbmanager@gmail.com
- Recruiting
Social Welfare Council - National Disabled Fund
Kathmandu, 3249
Yeti Raj Niraula, 9810031819, ext. +977, yr.niraula@hi.org
Ram Bahadur Thapa, 9841155157 ext. +977, rampo.ndf@gmail.com
- Recruiting
Prerana Rehabilitation Center
Sarlahi, Malangawa, 45800
Min Prasad Gurung, 9841039153 ext. +977, mingurung687@gmail.com
About this study
Official title: Evaluating the Relevance of Social and Professional Reintegration Improvements With a Set of Solutions for People With Upper Limb Amputation: Longitudinal Analysis of 2 Cohorts in Selected Areas of Nepal.
ORTHOPUS develops assistive technologies to address the lack of availability of medical devices in low and middle income countries.
With the help of HI (Handicap International) Nepal, the need for upper limb prostheses was identified. Indeed, according to the literature - especially Efficiency of voluntary opening hand and hook prosthetic devices: 24 years of development? (JRRD, Volume 49, Number 4, 2012) -, today available solutions do not fully address patients' needs.
Read more
In Nepal, only 2 upper limb prostheses options are generally proposed to patients because of supply and cost constraints.
ORTHOPUS' objective is to extend patients' autonomy with a new set of prosthetic solutions. By offering low cost but high quality devices (according to CE marking requirements), another of the ORTHOPUS' missions is also to address supply and cost constraints.
To improve patients' capabilities, ORTHOPUS aims at extending grasping capabilities compared to the usual passive aesthetic hand or voluntary opening one by proposing the following set of solutions:
- an aesthetic articulated hand
- a mechanical wrist
- a work hook
In order to assess the different stated hypotheses, a clinical trial is set jointly with HI Nepal. 14 patients will be enrolled in 2 cohorts (n1 = 7, n2 = 7), the first one is constituted with patients usually using an aesthetic passive hand whereas the second one comprise patients normally equipped with voluntary opening hand.
After selecting and getting the informed consent of the patients, a month to make the sockets and adapt it to patients is planned. An evaluation of their quality of life will be done with the WHO QOL - BREF quality of life assessment before and after the test period of the trial.
ORTHOPUS' set of prosthetic solutions will be tested by them over one month. They will have to fill on a daily basis a survey (OPUS) assessing their use of the prostheses. At the end of the test period, different questionnaires and surveys will be filled during a last interview to collect data.
Data will be analysed in order to extract evidence for or against the trial hypotheses. With these results, a report will be written and submitted to the GATE (Global Cooperation on Assistive Health Technology) community managed by WHO. This report will also feed the ORTHOPUS R\&D with patients' feedbacks and, research findings will be shared publicly on different social media in respect with patient privacy.
Read the detailed description
BACKGROUND
ORTHOPUS is a french private company founded in 2018 with the mission of increasing access to assistive technology like prosthetics care. ORTHOPUS focuses its actions on low and middle income countries with a model that mixes social impact (open source, frugal innovation, fair pricing) and medical european quality (CE marking).
Today, over 1 billion people need at least one form of Assistive Technology (AT), but over 900 million people (90%) do not have access to the AT they require.
The number of people who need AT is expected to grow to more than 2 billion people by 2050 according to the WHO "Assistive Technology Fact Sheet 18 May 2018". 80% of these persons live in a Low or Middle Income Country (LMIC).
According to World Health Organization estimation, 0.5% of the populations need these services and a report from the United Nations highlights that 0.7% of the Nepalese populations are physically disabled - NEPAL: Disabled Population 2011, (UNRCHCO, 2011). Prosthetics and Orthotics (P\&O) service is the subset of rehabilitation service, and National health policy 2019 has identified rehabilitation as core health services .
Compared to other assistive products such as crutches and walkers, P\&O services are very scarcely available in Nepal, even-though its need is going higher due to the increasing prevalence of NCDs and road traffic injury.
Living Conditions among People with Disability in Nepal report (SINTEF, 2015) highlights that 73 percent of people with disabilities do not have access to Assistive Devices.
According to WHO, failure of health policies, excessive prices of products, provision difficulties and insufficient training of health personnel are the 4 reasons for this problem.
RATIONALE
ORTHOPUS objective is to address some of the problem highlighted by WHO:
- To address LMIC product-related problems, ORTHOPUS proposes quality prosthetic solutions with a moderate price by designing innovative solutions based on the frugal innovation concept
- To address Information transmission and Health care practitioner formation, all ORTHOPUS' solutions will be shared via a free/Open source licence
- In order to guarantee the quality of medical devices, ORTHOPUS follows European standards certification process for each and every product.
Nepal is one of the target countries of the ORTHOPUS objective as the 2011 Nepal Census conducted by the government of Nepal reported that 1.94% of the total population of Nepal is living with some kind of disabilities. The number will be more if the 'functioning' status of the population is considered.
Moreover, the Living Conditions among People with Disability in Nepal report (SINTEF, 2015) highlights that 83 percent of people with disabilities do not have access to rehabilitation services and that there is a 72.5% service gap in Assistive Devices.
Today, according to the Principal Investigator of the trial, the most popular solutions provided by healthcare practitioners, in LMICs such as Nepal, for transradial amputation is a voluntary opening hand or a passive aesthetics one.
The voluntary opening hand is a compromise between efficiency and aesthetics according to the publication Efficiency of voluntary opening hand and hook prosthetic devices: 24 years of development? (JRRD, Volume 49, Number 4, 2012).
On the other hand, the passive aesthetic solution does not provide any active grasping functionalities but has an important social impact for users hiding the limb loss to a certain extent.
In addition, Nepal was chosen for ORTHOPUS first clinical trial thanks to the help of HI (Humanity and Inclusion) NGO who has already a program there. HI staff, Yeti Raj Niraula, will be the principal investigator of this clinical trial.
This clinical trial will focus on upper-limb prostheses. ORTHOPUS wants to demonstrate that a set of solutions composed of multiple medical devices such as:
- a wrist with a possible pronosupination as well as a rotational lock and a quick connection/disconnection feature.
- an aesthetic articulated hand, similar to usual aesthetic passive hand proposed nowadays in Nepal but with an additional articulation feature
- a heavy duty work hook used as a working tool to address the shortage of heavy duty prosthetic products in the country. The trial aims at assessing if using this solution will improve work integration of the user.
- a harness used to actuate the work hook allowing the user to open it with muscular contraction of the upper part of the torso
With this trial, improvement of the autonomy of users and on the well-being in everyday life will be studied compared to the sole use of a voluntary opening hand or a passive aesthetics one.
GENERAL OBJECTIVE
The general objective is to show the relevance of using the set of solutions made by ORTHOPUS (aesthetic articulated hand, working hook and quick disconnect wrist) compared to the widespread solution of a voluntary opening hand or passive aesthetic one.
SPECIFIC OBJECTIVE
To establish the effect of the ORTHOPUS prosthetic solution, four primary objectives will be studied to address the scientific question by collecting appropriate data:
- improvement of grasping capacities
- improvement of quality of life
- improvement of sociodemographic conditions
- evaluation of prosthesis perception
To address the primary objectives of the trial the following subjective primary endpoints will be measured:
- improvement of grasping capacities will be evaluated using an adapted to Nepali culture OPUS survey (Development and measurement properties of the Orthotics and Prosthetics Users' Survey (OPUS): a comprehensive set of clinical outcome instruments, A W Heinemann, 2003). Participants will be ranking the ease of realisation of a 30 item list using ORTHOPUS prosthetic solution. These ranks will be compared to the one obtained using the previous prosthetic solution (if applicable). Studying results to the survey, a conclusion on the evolution of the grasping capacities of users will be formulated.
- improvement of quality of life will be evaluated using the WHOQoL-BREF questionnaire (World Health Organisation, Program of Mental Health. WHOQOL-BREF : introduction, administration, scoring and generic version of the assessment : field trial version. 1996). Participants will be asked to answer 27 questions with ranked propositions before and after the test phase of the clinical trial. Scores will be compared to evaluate improvements brought by the ORTHOPUS prosthetic solution on the quality of life of the user and a conclusion will be drawn.
- improvement of sociodemographic conditions will be evaluated using a questionnaire written following the guidance of guidelines Standardization and Harmonization of Socio-Demographic Variables (2016, GESIS Survey Guidelines). Again a comparison of the answers to the 28 entries of the form will be made confronting questionnaires filled before and after the clinical trial test phase.
- evaluation of prosthesis perception will be conducted using a questionnaire filled by participants at the end of the test phase of the clinical trial. Analysis of the ranks given to the 90 entries will allow to draw a precise picture of the participants' perception of the ORTHOPUS prosthesis solution. With these results a conclusion will be drawn on the ORTHOPUS' solution improvements that needs to be performed to improve future users' perception.
Results of evaluations of objectives achievements will be used to feed ORTHOPUS' R\&D department in order to improve the studied prosthetic solution or to launch development of new products.
RESEARCH HYPOTHESIS
Nowadays, in Nepal, most of the patients are equipped with either a voluntary opening hand or a passive aesthetic one. These solutions present grasping capabilities or aesthetics limitations (see additional document attached to the registration: Comparative scheme - Standard VS ORTHOPUS prosthetic solutions.pdf) and we hypothesize that the ORTHOPUS prosthetic solution will expand it.
In addition with this grasping capabilities expansion, we hypothesize that, compared to previously used prosthetic solution, the set of ORTHOPUS upper limb prosthetics solutions will:
- improve the autonomy of users (professional reintegration with the ability to perform manual work)
- improve the well-being in everyday life (social reintegration)
For the patient selection, we hypothesize that two different cohorts will be enough to discriminate the data and make good clinical trial conclusions.
The first cohort will be composed of prosthetic users usually equipped with aesthetic passive hand solutions. The second one with a voluntary opening hand user. Data gathered from both cohorts will allow a direct comparison between the use of voluntary opening hand or passive aesthetic one (according to the cohort) and the use of the ORTHOPUS prosthetic solution.
- Conditions
- Amputation; Traumatic, Arm, Upper, Amputation; Traumatic, Arm: Forearm, Amputation; Traumatic, Hand, at Wrist Level, Wounds and Injuries
- Being tested
- ORTHOPUS prosthetic accessory: 0109 - Universal Wrist, ORTHOPUS prosthetic terminal device: 0112 - Hook, ORTHOPUS prosthetic terminal device: 0105 - Cosmetic Articulated Hand, ORTHOPUS prosthetic accessory: 0104 - body powered harness
- Keywords
- amputation, transradial, prosthesis, terminal device, upper limb amputation, upper extremity
- Medical subject headings
- Wounds and Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ORTHOPUS prosthetic accessory: 0109 - Universal WristDevice
The ORTHOPUS mechanical wrist device is intended to provide an external wrist joint only for external upper limb prostheses with pronation/supination passive motion (activation with external force), a quick connection (with automatic lock) and manual disconnection of the mechanical wrist connectors.
The mechanical wrist connector allows to quickly switch between different type of terminal devices (hand or tools).
ORTHOPUS prosthetic terminal device: 0112 - HookDevice
The ORTHOPUS body-powered hook is a Voluntary Opening (VO) device made of aluminium intended to provide high grasping capabilities under harsh environments.
ORTHOPUS prosthetic terminal device: 0105 - Cosmetic Articulated HandDevice
The ORTHOPUS cosmetic articulated hand is intended to provide a replacement limb in order to hide the loss of the original one. It is composed of an aesthetic glove (18 colors and 3 sizes, silicone made) and of an internal structure that can be bent to achieve a given position allowing the user to grasp small and light objects.
ORTHOPUS prosthetic accessory: 0104 - body powered harnessDevice
The ORTHOPUS body powered harness is intended to allow the patient to actuate the 0112 - Hook device. It will be installed on the patient's contralateral shoulder and linked to the 0112 - Hook device with a cable.
| Study group | Role | What they receive |
|---|---|---|
| Participants using the ORTHOPUS set of prosthetic solution | Experimental | Not described Receives: Device: ORTHOPUS prosthetic accessory: 0109 - Universal Wrist; Device: ORTHOPUS prosthetic terminal device: 0112 - Hook; Device: ORTHOPUS prosthetic terminal device: 0105 - Cosmetic Articulated Hand; Device: ORTHOPUS prosthetic accessory: 0104 - body powered harness |
What is being measured
The primary outcome is the main question the study is designed to answer.
Functionalities of the prosthetic solution
Users' feedback will be gathered from his/her experiences and quantitative data will be collected using the "OPUS Upper Extremity Functional Status" survey, which allows us to evaluate the contribution of the set of solutions to the accomplishment of daily life tasks. For each activity, the user will evaluate the difficulty of performing the activity (very easy; easy; slightly difficult; very difficult; cannot perform the task; not applicable), and will specify whether or not he or she usually uses his or her prosthesis in performing the task.
Measured: 1 month
Quality of life evolution
Quality of life will be evaluated with the "WHO QOL - BREF quality of life assessment". The form is composed of checkboxes entries ranking from: very low, low, neither good nor low, good, very good. Users will have to fill in the form twice: once before the patient testing and a then at the end of it. This will allow a comparison of the results and the determination of a potential improvement.
Measured: 1.5 month
Prosthesis perception
Prosthesis perception will be evaluated with a final questionnaire created by ORTHOPUS to collect users' feedback on aesthetics, functionalities and sensations. These aspects will be evaluated with scores from 1 to 5.
Measured: 1.5 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Mar 2021
- Study start6 Sep 2021
- Primary completionJan 2022 (estimated)
- Study completionFeb 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Amputation; Traumatic, Arm, UpperStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 14 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Orthopus
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Handicap International
- Responsible party
- Sponsor
- Investigators
- David Gouaillier, PhD, Study director, Orthopus
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04803253
- Sponsor's protocol ID
- CST-0404-201006
- Status last verified
- Sep 2021
- First submitted
- 15 Mar 2021
- Last updated
- 16 Sep 2021
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Sep 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluating the Relevance of Social and Professional Reintegration Improvements With a Set of Solutions for People With Upper Limb Amputation: Longitudinal Analysis of 2 Cohorts in Selected Areas of Nepal.
- ClinicalTrials.gov ID
- NCT04803253
- Acronym / sponsor ID
- CST-0404-201006
- Conditions
- Amputation; Traumatic, Arm, Upper, Amputation; Traumatic, Arm: Forearm, Amputation; Traumatic, Hand, at Wrist Level, Wounds and Injuries
- Keywords
- amputation, transradial, prosthesis, terminal device, upper limb amputation, upper extremity
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 14 participants (estimated)
- Lead sponsor
- OrthopusIndustry (pharma, biotech, devices)
- Collaborators
- Handicap International
- Study start
- 6 Sep 2021 (actual)
- Primary completion
- Jan 2022 (estimated)
- Study completion
- Feb 2022 (estimated)
- First posted
- 17 Mar 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
ORTHOPUS develops assistive technologies to address the lack of availability of medical devices in low and middle income countries.
With the help of HI (Handicap International) Nepal, the need for upper limb prostheses was identified. Indeed, according to the literature - especially Efficiency of voluntary opening hand and hook prosthetic devices: 24 years of development? (JRRD, Volume 49, Number 4, 2012) -, today available solutions do not fully address patients' needs.
In Nepal, only 2 upper limb prostheses options are generally proposed to patients because of supply and cost constraints.
ORTHOPUS' objective is to extend patients' autonomy with a new set of prosthetic solutions. By offering low cost but high quality devices (according to CE marking requirements), another of the ORTHOPUS' missions is also to address supply and cost constraints.
To improve patients' capabilities, ORTHOPUS aims at extending grasping capabilities compared to the usual passive aesthetic hand or voluntary opening one by proposing the following set of solutions:
- an aesthetic articulated hand
- a mechanical wrist
- a work hook
In order to assess the different stated hypotheses, a clinical trial is set jointly with HI Nepal. 14 patients will be enrolled in 2 cohorts (n1 = 7, n2 = 7), the first one is constituted with patients usually using an aesthetic passive hand whereas the second one comprise patients normally equipped with voluntary opening hand.
After selecting and getting the informed consent of the patients, a month to make the sockets and adapt it to patients is planned. An evaluation of their quality of life will be done with the WHO QOL - BREF quality of life assessment before and after the test period of the trial.
ORTHOPUS' set of prosthetic solutions will be tested by them over one month. They will have to fill on a daily basis a survey (OPUS) assessing their use of the prostheses. At the end of the test period, different questionnaires and surveys will be filled during a last interview to collect data.
Data will be analysed in order to extract evidence for or against the trial hypotheses. With these results, a report will be written and submitted to the GATE (Global Cooperation on Assistive Health Technology) community managed by WHO. This report will also feed the ORTHOPUS R\&D with patients' feedbacks and, research findings will be shared publicly on different social media in respect with patient privacy.
Detailed description
BACKGROUND
ORTHOPUS is a french private company founded in 2018 with the mission of increasing access to assistive technology like prosthetics care. ORTHOPUS focuses its actions on low and middle income countries with a model that mixes social impact (open source, frugal innovation, fair pricing) and medical european quality (CE marking).
Today, over 1 billion people need at least one form of Assistive Technology (AT), but over 900 million people (90%) do not have access to the AT they require.
The number of people who need AT is expected to grow to more than 2 billion people by 2050 according to the WHO "Assistive Technology Fact Sheet 18 May 2018". 80% of these persons live in a Low or Middle Income Country (LMIC).
According to World Health Organization estimation, 0.5% of the populations need these services and a report from the United Nations highlights that 0.7% of the Nepalese populations are physically disabled - NEPAL: Disabled Population 2011, (UNRCHCO, 2011). Prosthetics and Orthotics (P\&O) service is the subset of rehabilitation service, and National health policy 2019 has identified rehabilitation as core health services .
Compared to other assistive products such as crutches and walkers, P\&O services are very scarcely available in Nepal, even-though its need is going higher due to the increasing prevalence of NCDs and road traffic injury.
Living Conditions among People with Disability in Nepal report (SINTEF, 2015) highlights that 73 percent of people with disabilities do not have access to Assistive Devices.
According to WHO, failure of health policies, excessive prices of products, provision difficulties and insufficient training of health personnel are the 4 reasons for this problem.
RATIONALE
ORTHOPUS objective is to address some of the problem highlighted by WHO:
- To address LMIC product-related problems, ORTHOPUS proposes quality prosthetic solutions with a moderate price by designing innovative solutions based on the frugal innovation concept
- To address Information transmission and Health care practitioner formation, all ORTHOPUS' solutions will be shared via a free/Open source licence
- In order to guarantee the quality of medical devices, ORTHOPUS follows European standards certification process for each and every product.
Nepal is one of the target countries of the ORTHOPUS objective as the 2011 Nepal Census conducted by the government of Nepal reported that 1.94% of the total population of Nepal is living with some kind of disabilities. The number will be more if the 'functioning' status of the population is considered.
Moreover, the Living Conditions among People with Disability in Nepal report (SINTEF, 2015) highlights that 83 percent of people with disabilities do not have access to rehabilitation services and that there is a 72.5% service gap in Assistive Devices.
Today, according to the Principal Investigator of the trial, the most popular solutions provided by healthcare practitioners, in LMICs such as Nepal, for transradial amputation is a voluntary opening hand or a passive aesthetics one.
The voluntary opening hand is a compromise between efficiency and aesthetics according to the publication Efficiency of voluntary opening hand and hook prosthetic devices: 24 years of development? (JRRD, Volume 49, Number 4, 2012).
On the other hand, the passive aesthetic solution does not provide any active grasping functionalities but has an important social impact for users hiding the limb loss to a certain extent.
In addition, Nepal was chosen for ORTHOPUS first clinical trial thanks to the help of HI (Humanity and Inclusion) NGO who has already a program there. HI staff, Yeti Raj Niraula, will be the principal investigator of this clinical trial.
This clinical trial will focus on upper-limb prostheses. ORTHOPUS wants to demonstrate that a set of solutions composed of multiple medical devices such as:
- a wrist with a possible pronosupination as well as a rotational lock and a quick connection/disconnection feature.
- an aesthetic articulated hand, similar to usual aesthetic passive hand proposed nowadays in Nepal but with an additional articulation feature
- a heavy duty work hook used as a working tool to address the shortage of heavy duty prosthetic products in the country. The trial aims at assessing if using this solution will improve work integration of the user.
- a harness used to actuate the work hook allowing the user to open it with muscular contraction of the upper part of the torso
With this trial, improvement of the autonomy of users and on the well-being in everyday life will be studied compared to the sole use of a voluntary opening hand or a passive aesthetics one.
GENERAL OBJECTIVE
The general objective is to show the relevance of using the set of solutions made by ORTHOPUS (aesthetic articulated hand, working hook and quick disconnect wrist) compared to the widespread solution of a voluntary opening hand or passive aesthetic one.
SPECIFIC OBJECTIVE
To establish the effect of the ORTHOPUS prosthetic solution, four primary objectives will be studied to address the scientific question by collecting appropriate data:
- improvement of grasping capacities
- improvement of quality of life
- improvement of sociodemographic conditions
- evaluation of prosthesis perception
To address the primary objectives of the trial the following subjective primary endpoints will be measured:
- improvement of grasping capacities will be evaluated using an adapted to Nepali culture OPUS survey (Development and measurement properties of the Orthotics and Prosthetics Users' Survey (OPUS): a comprehensive set of clinical outcome instruments, A W Heinemann, 2003). Participants will be ranking the ease of realisation of a 30 item list using ORTHOPUS prosthetic solution. These ranks will be compared to the one obtained using the previous prosthetic solution (if applicable). Studying results to the survey, a conclusion on the evolution of the grasping capacities of users will be formulated.
- improvement of quality of life will be evaluated using the WHOQoL-BREF questionnaire (World Health Organisation, Program of Mental Health. WHOQOL-BREF : introduction, administration, scoring and generic version of the assessment : field trial version. 1996). Participants will be asked to answer 27 questions with ranked propositions before and after the test phase of the clinical trial. Scores will be compared to evaluate improvements brought by the ORTHOPUS prosthetic solution on the quality of life of the user and a conclusion will be drawn.
- improvement of sociodemographic conditions will be evaluated using a questionnaire written following the guidance of guidelines Standardization and Harmonization of Socio-Demographic Variables (2016, GESIS Survey Guidelines). Again a comparison of the answers to the 28 entries of the form will be made confronting questionnaires filled before and after the clinical trial test phase.
- evaluation of prosthesis perception will be conducted using a questionnaire filled by participants at the end of the test phase of the clinical trial. Analysis of the ranks given to the 90 entries will allow to draw a precise picture of the participants' perception of the ORTHOPUS prosthesis solution. With these results a conclusion will be drawn on the ORTHOPUS' solution improvements that needs to be performed to improve future users' perception.
Results of evaluations of objectives achievements will be used to feed ORTHOPUS' R\&D department in order to improve the studied prosthetic solution or to launch development of new products.
RESEARCH HYPOTHESIS
Nowadays, in Nepal, most of the patients are equipped with either a voluntary opening hand or a passive aesthetic one. These solutions present grasping capabilities or aesthetics limitations (see additional document attached to the registration: Comparative scheme - Standard VS ORTHOPUS prosthetic solutions.pdf) and we hypothesize that the ORTHOPUS prosthetic solution will expand it.
In addition with this grasping capabilities expansion, we hypothesize that, compared to previously used prosthetic solution, the set of ORTHOPUS upper limb prosthetics solutions will:
- improve the autonomy of users (professional reintegration with the ability to perform manual work)
- improve the well-being in everyday life (social reintegration)
For the patient selection, we hypothesize that two different cohorts will be enough to discriminate the data and make good clinical trial conclusions.
The first cohort will be composed of prosthetic users usually equipped with aesthetic passive hand solutions. The second one with a voluntary opening hand user. Data gathered from both cohorts will allow a direct comparison between the use of voluntary opening hand or passive aesthetic one (according to the cohort) and the use of the ORTHOPUS prosthetic solution.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Participants using the ORTHOPUS set of prosthetic solution | Experimental | Device: ORTHOPUS prosthetic accessory: 0109 - Universal Wrist, Device: ORTHOPUS prosthetic terminal device: 0112 - Hook, Device: ORTHOPUS prosthetic terminal device: 0105 - Cosmetic Articulated Hand, Device: ORTHOPUS prosthetic accessory: 0104 - body powered harness |
Who may qualify
- Ages
- 20 to 50 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (8 listed)
- Unilateral transradial or wrist-disarticulation amputee
- 20 to 50 years of age
- At least 1 year from date of amputation
- Have been using upper limb prosthesis previously
- Be able to independently provide informed and independant consent
Key exclusion criteria (8 listed)
- Congenital anomaly of upper limb
- Bilateral wrist disarticulation or transradial amputation
- Any condition that would prevent participation and pose increased risk (e.g. shoulder impingement, sub-acromial bursitis, severe arthritis of the shoulder, elbow, wrist, or fingers)
- Injuries of the upper limb within the past 90 days (surgeries, sprains, strains, or fractures).
- Younger than 20 or older than 50 years of age
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ORTHOPUS prosthetic accessory: 0109 - Universal WristThe ORTHOPUS mechanical wrist device is intended to provide an external wrist joint only for external upper limb prostheses with pronation/supination passive motion (activation with external force), a quick connection (with automatic lock) and manual disconnection of the mechanical wrist connectors. The mechanical wrist connector allows to quickly switch between different type of terminal devices (hand or tools). | Device | Participants using the ORTHOPUS set of prosthetic solution |
| ORTHOPUS prosthetic terminal device: 0112 - HookThe ORTHOPUS body-powered hook is a Voluntary Opening (VO) device made of aluminium intended to provide high grasping capabilities under harsh environments. | Device | Participants using the ORTHOPUS set of prosthetic solution |
| ORTHOPUS prosthetic terminal device: 0105 - Cosmetic Articulated HandThe ORTHOPUS cosmetic articulated hand is intended to provide a replacement limb in order to hide the loss of the original one. It is composed of an aesthetic glove (18 colors and 3 sizes, silicone made) and of an internal structure that can be bent to achieve a given position allowing the user to grasp small and light objects. | Device | Participants using the ORTHOPUS set of prosthetic solution |
| ORTHOPUS prosthetic accessory: 0104 - body powered harnessThe ORTHOPUS body powered harness is intended to allow the patient to actuate the 0112 - Hook device. It will be installed on the patient's contralateral shoulder and linked to the 0112 - Hook device with a cable. | Device | Participants using the ORTHOPUS set of prosthetic solution |
Primary outcome
Functionalities of the prosthetic solution
Time frame: 1 month
Users' feedback will be gathered from his/her experiences and quantitative data will be collected using the "OPUS Upper Extremity Functional Status" survey, which allows us to evaluate the contribution of the set of solutions to the accomplishment of daily life tasks. For each activity, the user will evaluate the difficulty of performing the activity (very easy; easy; slightly difficult; very difficult; cannot perform the task; not applicable), and will specify whether or not he or she usually uses his or her prosthesis in performing the task.
Quality of life evolution
Time frame: 1.5 month
Quality of life will be evaluated with the "WHO QOL - BREF quality of life assessment". The form is composed of checkboxes entries ranking from: very low, low, neither good nor low, good, very good. Users will have to fill in the form twice: once before the patient testing and a then at the end of it. This will allow a comparison of the results and the determination of a potential improvement.
Prosthesis perception
Time frame: 1.5 month
Prosthesis perception will be evaluated with a final questionnaire created by ORTHOPUS to collect users' feedback on aesthetics, functionalities and sensations. These aspects will be evaluated with scores from 1 to 5.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Sep 2021.
- Individual participant dataSharing planned: No
Related trials for Amputation; Traumatic, Arm, Upper
RecruitingObservational study
Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain
Amputation, Amputation of Lower Limb
RecruitingPhase 2
Human Upper Extremity Allotransplantation
Amputation, Traumatic, Wounds and Injuries
RecruitingObservational study
Human Upper Extremity Allotransplantation: F/U Protocol
Amputation, Traumatic, Wounds and Injury
Recruiting
Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control
Amputation, Amputation, Traumatic
Not yet recruiting
Neuromusculoskeletal Interface for Bionic Arms
Amputation, Amputation, Traumatic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
David Gouaillier, PhD study director
Orthopus
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ORTHOPUS prosthetic accessory: 0109 - Universal Wrist, ORTHOPUS prosthetic terminal device: 0112 - Hook and ORTHOPUS prosthetic terminal device: 0105 - Cosmetic Articulated Hand in people with Amputation; Traumatic, Arm, Upper and Amputation; Traumatic, Arm: Forearm, run by Orthopus at 3 sites in Nepal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 16 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Nepal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Thibault Davasse (0652341166 ext. +33, thibault.davasse@orthopus.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Functionalities of the prosthetic solution (time frame: 1 month). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2021.